In patients with LN and other CKDs, such as IgAN, minimal change disease, hypertensive nephropathy, and DN, elevated urinary vimentin mRNA levels correlate with increased proteinuria, renal fibrosis scores, and a decrease in GFR, highlighting its potential as a diagnostic marker for renal outcomes [39]. The gene discussed is VIM; the disease is lobular neoplasia.